Compare VERA & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VERA | DNUT |
|---|---|---|
| Founded | 2016 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 577.8M |
| IPO Year | 2021 | 2021 |
| Metric | VERA | DNUT |
|---|---|---|
| Price | $33.27 | $2.99 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 5 |
| Target Price | ★ $81.30 | $4.15 |
| AVG Volume (30 Days) | ★ 2.3M | 2.0M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,522,616,000.00 |
| Revenue This Year | N/A | $0.55 |
| Revenue Next Year | $472.48 | $3.59 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $23.05 | $2.88 |
| 52 Week High | $56.05 | $5.11 |
| Indicator | VERA | DNUT |
|---|---|---|
| Relative Strength Index (RSI) | 46.10 | 36.40 |
| Support Level | $30.05 | $2.88 |
| Resistance Level | $33.09 | $3.35 |
| Average True Range (ATR) | 2.15 | 0.09 |
| MACD | -0.09 | -0.02 |
| Stochastic Oscillator | 28.23 | 10.64 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Krispy Kreme Inc is a sweet-treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations world-wide. It derives maximum revenue from the U.S. segment.